Analyst Reco. BioNTech SE Börse Stuttgart

Equities

Market Closed - Börse Stuttgart Other stock markets 20:59:21 17/05/2024 BST			5-day change	1st Jan Change
83.25 ^EUR	-2.52%		-0.23%	-6.21%

05-17	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
05-17	Sector Update: Health Care Stocks Softer Friday Afternoon	MT

Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	05-17	MT
Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target	05-14	MT
BIONTECH : UBS remains Neutral	05-10	ZD
HC Wainwright Raises BioNTech SE Price Target to $113 From $107, Maintains Buy Rating	05-08	MT
BIONTECH : Deutsche Bank reaffirms its Neutral rating	05-08	ZD
TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating	05-07	MT
BMO Capital Adjusts BioNTech Price Target to $122 From $123, Maintains Outperform Rating	05-07	MT
BIONTECH : Goldman Sachs reiterates its Neutral rating	05-07	ZD
BIONTECH : Jefferies gives a Neutral rating	05-06	ZD
BIONTECH : Gets a Neutral rating from Deutsche Bank	04-23	ZD
UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating	03-27	MT
BIONTECH : Deutsche Bank remains Neutral	03-22	ZD
TD Cowen Adjusts BioNTech Price Target to $95 From $101, Maintains Market Perform Rating	03-21	MT
BIONTECH : A miss is a miss	03-21
BIONTECH : Deutsche Bank reaffirms its Neutral rating	03-21	ZD
BIONTECH : Goldman Sachs reiterates its Neutral rating	03-21	ZD
BIONTECH : Jefferies sticks Neutral	03-20	ZD
BIONTECH : UBS gives a Neutral rating	03-20	ZD
BMO Capital Initiates Coverage on BioNTech With Outperform Rating, $127 Price Target	02-23	MT
Canaccord Genuity Adjusts Price Target on BioNTech to $171 From $168, Maintains Buy Rating	02-20	MT

No results for this search

BIONTECH : A miss is a miss

March 21, 2024 at 01:27 pm